BIOGEN INC.
BIIB · XNASCIK 875045fmd_1DA9376KC4PGRZ664PN82EB6NCIndustri Pengolahan · Produk biologis (tidak termasuk bahan diagnostik)Templat: Standar
Cakupan: 01 Jan 2007 hingga 30 Sep 2026, 75 periode
| Pos laporan | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total pendapatan | 11.449 | 12.274 | 13.453 | 14.378 | 13.445 | 10.982 | 10.173 | 9.836 | 9.676 | 9.891 |
| Beban pokok pendapatan | 1.479 | 1.630 | 1.816 | 1.955 | 1.805 | 2.110 | 2.278 | 2.533 | 2.310 | 2.404 |
| Laba kotor | 9.970 | 10.644 | 11.637 | 12.423 | 11.639 | 8.872 | 7.895 | 7.302 | 7.366 | 7.486 |
| Keuntungan (kerugian) investasi yang direalisasi | – | – | – | 50 | 12 | – | – | – | – | – |
| Penelitian dan pengembangan | 1.973 | 2.254 | 2.597 | 2.281 | 3.991 | 2.501 | 2.231 | 2.445 | 1.980 | 1.779 |
| Beban penjualan, umum dan administrasi | 1.947 | 1.934 | 2.106 | 2.375 | 2.505 | 2.674 | 2.404 | 2.550 | 2.404 | 2.434 |
| Laba operasi | 5.152 | 5.346 | 5.889 | 7.043 | 4.550 | 2.841 | – | – | – | – |
| Beban bunga | 260 | 251 | 201 | 187 | 223 | 254 | 247 | 247 | 250 | 268 |
| Pendapatan bunga dan investasi | 63 | 79 | 113 | 120 | 42 | 11 | 89 | 277 | 68 | 125 |
| Pendapatan (beban) nonoperasi lainnya | (219) | (217) | 11 | 83 | 497 | (1.096) | 108 | (316) | (344) | (306) |
| Laba sebelum pajak | 4.933 | 5.129 | 5.900 | 7.126 | 5.048 | 1.745 | 3.592 | 1.297 | 1.906 | 1.557 |
| Beban pajak penghasilan | 1.237 | 2.459 | 1.426 | 1.158 | 992 | 53 | 633 | 135 | 274 | 264 |
| Laba bersih dari operasi yang dilanjutkan | 3.696 | 2.670 | 4.474 | 5.968 | 4.055 | 1.693 | 2.959 | 1.162 | 1.632 | 1.293 |
| Laba bersih | 3.703 | 2.539 | 4.431 | 5.889 | 4.001 | 1.556 | 3.047 | 1.161 | 1.632 | 1.293 |
| Laba bersih yang diatribusikan kepada pemegang saham biasa | – | – | – | – | – | – | – | – | – | – |